EUVIMEDEUVIMED entdecken
Crossref

CON: Patients With Metastatic/Recurrent Cervical Cancer Should Not be Treated With Cisplatin Plus Paclitaxel

J. Tate Thigpen

Clinical Ovarian Cancer · 2011

DOI: 10.1016/j.cloc.2012.02.015 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Ovarian Cancer, 2011. Verfasst von J. Tate Thigpen. Die Arbeit nennt 19 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Thigpen, J. T. (2011). CON: Patients With Metastatic/Recurrent Cervical Cancer Should Not be Treated With Cisplatin Plus Paclitaxel. Clinical Ovarian Cancer. https://doi.org/10.1016/j.cloc.2012.02.015

Vancouver

Thigpen JT. CON: Patients With Metastatic/Recurrent Cervical Cancer Should Not be Treated With Cisplatin Plus Paclitaxel. Clinical Ovarian Cancer. 2011. doi:10.1016/j.cloc.2012.02.015

BibTeX
@article{Thigpen2011,
  author = {Thigpen, J. Tate},
  title = {CON: Patients With Metastatic/Recurrent Cervical Cancer Should Not be Treated With Cisplatin Plus Paclitaxel},
  journal = {Clinical Ovarian Cancer},
  year = {2011},
  doi = {10.1016/j.cloc.2012.02.015}
}
Kostenlos starten →